Volume 3, Issue 1, p1-23

Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.

Maintenance of [Met5]-enkephalin Blood Levels Corresponds with a Positive Outcome in Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating disease with a multifactorial etiology that remains to be fully defined. In the United States alone it is estimated that there are one million individuals living with MS.

J Exp Neurol, 2022, Volume 3, Issue 1, p1-4 | DOI: 10.33696/Neurol.3.053

Caring for the Vulnerable and Disadvantaged

Ischemic stroke carries a high readmission rate [1]. Among Medicare beneficiaries hospitalized for acute ischemic stroke, 14.1% were readmitted within 30 days, 29.2% within 90 days, and 55.3% within 1 year [1]. 

J Exp Neurol, 2022, Volume 3, Issue 1, p5-7 | DOI: 10.33696/Neurol.3.054

Virtual Reality Zoo Therapy: An Interactive Relaxing System for Alzheimer’s Disease

The number of people with Alzheimer’s disease (AD) is on the rise, yet there is no effective pharmacological treatment that can slow or reverse the disease’s progress

J Exp Neurol, 2022, Volume 3, Issue 1, p15-19 | DOI: 10.33696/Neurol.3.057
Submit Manuscript